Massive Tech firms are serving to propel third-quarter earnings development, however some analysts are much less optimistic a couple of handful of names reporting subsequent week. As of Tuesday, roughly 42% of S & P 500 firms had reported monetary outcomes and collectively notched development of greater than 6%, based on FactSet. However the forecast for blended development, which takes under consideration estimates for earnings which have but to be reported, is a extra measured 4.89%. To assist buyers put together for what continues to be to return, CNBC Professional screened FactSet information to search out shares reporting subsequent week the place analysts are dropping conviction. Among the many names that surfaced are AIG and CVS Well being . Shares on the listing are members of the S & P 500 Earnings are due subsequent week Earnings per share estimates have been trimmed 10% or extra over the previous three and 6 months Inventory in agriculture Archer-Daniels-Midland has pulled again greater than 21% in 2024. Analysts have trimmed their earnings estimates by greater than 21% over the previous three months and 29% over the trailing six months. Third-quarter outcomes are due out Tuesday. ADM YTD mountain Archer-Daniels inventory. The agency paused carbon dioxide injections at an Illinois carbon seize and storage plant earlier in October, after discovering an underground leak . Extra lately, the corporate was sued for misconduct and missing security protocols . Shares of finance and insurance coverage agency AIG have superior almost 14% in 2024. What’s extra is analysts have lowered earnings estimates almost 30% over the previous three months and roughly 24% over the previous six months. BMO Capital Markets analyst Michael Zaremski downgraded AIG inventory to market carry out from outperform earlier in October, citing issues that AIG will proceed to lag friends within the insurance coverage sector and that the inventory might face headwinds as market situations total stay delicate. AIG YTD mountain AIG inventory. “AIG’s shares have underperformed friends YTD (AIG +~13%) and sentiment stays extra muted as buyers digest AIG’s new working construction, plus the potential for M & A [mergers & acquisitions],” Zaremski mentioned in an Oct. 15 notice. AIG will report third-quarter outcomes on Monday. Different names on the listing embody chemical shares Albemarle and Corteva .